0001209191-17-038858.txt : 20170609 0001209191-17-038858.hdr.sgml : 20170609 20170609160730 ACCESSION NUMBER: 0001209191-17-038858 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170607 FILED AS OF DATE: 20170609 DATE AS OF CHANGE: 20170609 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: NV FISCAL YEAR END: 1217 BUSINESS ADDRESS: STREET 1: 849 MITTEN ROAD STREET 2: SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-697-3939 MAIL ADDRESS: STREET 1: 849 MITTEN ROAD STREET 2: SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: UECKER DARRIN CENTRAL INDEX KEY: 0001276311 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 17902990 MAIL ADDRESS: STREET 1: 849 MITTEN ROAD, SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-07 0 0001625101 Pulse Biosciences, Inc. PLSE 0001276311 UECKER DARRIN 849 MITTEN ROAD, SUITE 104 BURLINGAME CA 94010 1 1 0 0 CEO and President Common Stock 2017-06-07 4 A 0 160974 0.00 A 160974 D Stock Option (right to buy) 30.99 2017-06-07 4 A 0 187286 0.00 A 2017-06-07 2027-06-07 Common Stock 187286 187286 D Stock Option (right to buy) 30.99 2017-06-07 4 A 0 195000 0.00 A 2017-06-07 2027-06-07 Common Stock 195000 195000 D Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will fully vest on June 1, 2018, subject to the Reporting Person's continued service as of that date. The shares subject to the option will vest in equal monthly installments over a four year period that began on June 21, 2016, subject to the Reporting Person's continued service through each vesting date. The shares subject to the option will vest in equal monthly installments over a four year period that began on February 15, 2017, subject to the Reporting Person's continued service through each vesting date. /s/ Brian Dow, as Attorney-in-Fact 2017-06-09